(Q51396890)

4 April 2018

title

Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro. (English)

1 reference

4 April 2018

author name string

F Murray

1

1 reference

4 April 2018

J Kennedy

2

1 reference

4 April 2018

P H Hutson

3

1 reference

4 April 2018

J Elliot

4

1 reference

4 April 2018

I Huscroft

5

1 reference

4 April 2018

K Mohnen

6

1 reference

4 April 2018

M G Russell

7

1 reference

4 April 2018

S Grimwood

8

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

4 April 2018

European Journal of Pharmacology

published in

1 reference

4 April 2018

volume

397

1 reference

4 April 2018

issue

2-3

1 reference

4 April 2018

page(s)

263-270

1 reference

4 April 2018

Glutamate and Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

(3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The pharmacological specificity of N-methyl-d-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Molecular diversity of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Glutamate receptors in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

In vivo labelling of the NMDA receptor channel complex by [3H]MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Neurochemical Interactions of Competitive N-Methyl-D-Aspartate Antagonists with Dopaminergic Neurotransmission and the Cerebellar Cyclic GMP System: Functional Evidence for a Phasic Glutamatergic Control of the Nigrostriatal Dopaminergic Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

[3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900263-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00263-6

1 reference

4 April 2018

1 reference

4 April 2018